Embryonic stem cell therapy is a complementary biological treatment which is employed to combat symptoms of premature ageing and chronic degenerative diseases. These extremely young and active cellular materials are procured from early embryos from specially bred sheep (formed at the very beginning of life) to trigger efficient repair, rejuvenation and regeneration of the human body.
Upon procurement, these embryonic stem cells undergo a rigorous and complex series of processes, from high tech filtration under stringent conditions, to cryogenic activity and lyophilising to preserve the biological composition and integrity of the cells. The lyophilised embryonic stem cells then can be securely transported around the world and reactivated again through reconstitution (where the lyophilised cells are hydrated with sterilised water). The product of these exclusive processes are from the International Association for Organ and Stem Cell Therapy Specialists, Switzerland, Germany & France (I.A.O.S.S.).
Embryonic stem cells are pluripotent (the ability of continuous cell renewal a.k.a. Regeneration), that is, they are able to differentiate into all derivatives of the three primary germ layers: ectoderm, endoderm, and mesenchyme – together they can regenerate more than 220 cell types in the adult body.